Stay updated on ACCORD Clinical Trial: Alzheimer's Agitation
Sign up to get notified when there's something new on the ACCORD Clinical Trial: Alzheimer's Agitation page.

Latest updates to the ACCORD Clinical Trial: Alzheimer's Agitation page
- Check2 days agoChange DetectedThe footer revision label was updated from v3.8.0 to v3.8.1.SummaryDifference0.0%

- Check9 days agoChange DetectedThe page now displays the completed ACCORD Phase 3 study record for AXS-05 in Alzheimer’s-related agitation, including its design, eligibility criteria, outcomes, and locations, instead of an error page.SummaryDifference68%

- Check16 days agoChange DetectedThe footer revision label changed from v3.7.2 to v3.8.0; the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check30 days agoChange DetectedA general NIH notice about the transition from “Artificial Intelligence” to “Super Intelligence” appears above the page, and the site revision changes from v3.7.1 to v3.7.2. The clinical-trial record itself remains unavailable behind a 403 error.SummaryDifference1%

- Check44 days agoChange DetectedThe site footer revision indicator changes from v3.7.0 to v3.7.1 while the page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check58 days agoChange DetectedAccess to the study record for NCT04797715 is blocked by a 403 Forbidden page, replacing the full study details with an access-denied message. The page now shows a 403 screen where the study content and navigation would normally appear.SummaryDifference17%

Stay in the know with updates to ACCORD Clinical Trial: Alzheimer's Agitation
Enter your email address, and we'll notify you when there's something new on the ACCORD Clinical Trial: Alzheimer's Agitation page.